{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:10:03Z","timestamp":1761808203661},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,15]]},"DOI":"10.2146\/ajhp170636","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T06:25:19Z","timestamp":1528352719000},"page":"847-849","source":"Crossref","is-referenced-by-count":5,"title":["Instruction on compounded sterile preparations at schools of pharmacy"],"prefix":"10.1093","volume":"75","author":[{"given":"Kaitlyn N.","family":"Dana","sequence":"first","affiliation":[{"name":"Center for Medication Safety Advancement Purdue University College of Pharmacy Fishers, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Hertig","sequence":"additional","affiliation":[{"name":"Center for Medication Safety Advancement Purdue University College of Pharmacy Fishers, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine R.","family":"Scott","sequence":"additional","affiliation":[{"name":"Center for Medication Safety Advancement Purdue University College of Pharmacy Fishers, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh","family":"Briscoe-Dwyer","sequence":"additional","affiliation":[{"name":"AmerisourceBergen PharMEDium Services, LLC Lake Forest, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041604202501000_b1-0750847","article-title":"Multistate outbreak of fungal meningitis and other infections","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"2019041604202501000_b2-0750847","article-title":"Current good manufacturing practice\u2014interim guidance for human drug compounding outsourcing facilities under section 503B of the FD&C Act","author":"Food and Drug Administration","year":"2014"},{"key":"2019041604202501000_b3-0750847","article-title":"Pharmacy compounding of human drug products under section 503A of the Federal Food, Drug, and Cosmetic Act guidance","author":"Food and Drug Administration","year":"2016"},{"key":"2019041604202501000_b4-0750847","article-title":". Pharmaceutical compounding\u2014sterile preparations (general chapter 797)","author":"United States Pharmacopeial Convention"},{"key":"2019041604202501000_b5-0750847","article-title":"Accreditation standards and key elements for the professional program in pharmacy leading to the doctor of pharmacy degree \u201cStandards 2016\u201d","author":"Accreditation Council for Pharmacy Education","year":"2015"},{"key":"2019041604202501000_b6-0750847","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2146\/ajhp060531","article-title":"Instruction on compounded sterile preparations at U.S. schools of pharmacy","volume":"64","author":"Hellums","year":"2007","journal-title":"Am J Health-Syst Pharm"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/75\/12\/847\/28450358\/ajhp0847.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T04:27:30Z","timestamp":1555388850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/75\/12\/847\/5101943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,6,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp170636","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,15]]},"published":{"date-parts":[[2018,6,15]]}}}